- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
E-Z-EM introduces MRM lesion marker
E-Z-EM of Westbury, NY, has introduced a new line of placementneedles and marking wires that are compatible with MRI scannersfor localizing lesions during MR mammography. The company's lesionmarking system is made of a special low-magnetic material
E-Z-EM of Westbury, NY, has introduced a new line of placement
needles and marking wires that are compatible with MRI scanners
for localizing lesions during MR mammography. The company's lesion
marking system is made of a special low-magnetic material that
is visible on MRI scans but does not distort images, according
to E-Z-EM.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
